Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer

被引:50
|
作者
Yuh, Bertram E. [1 ]
Ruel, Nora H. [1 ]
Mejia, Rosa [1 ]
Wilson, Chelsea M. [1 ]
Wilson, Timothy G. [1 ]
机构
[1] City Hope Natl Canc Ctr, Duarte, CA 90017 USA
关键词
Pelvic lymphadenectomy; Robotics; Positive lymph nodes; Prostate Cancer; LYMPH-NODE DISSECTION; RADICAL PROSTATECTOMY; IMPACT; METASTASES; MEN; YIELD;
D O I
10.1016/j.eururo.2012.01.048
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Accurate staging of prostate cancer is enhanced by a thorough evaluation of the pelvic lymph nodes. Limited data are available regarding robotic extended pelvic lymphadenectomy (PLA) in this setting. Objective: Analyze our experience performing robotic extended PLA. Design, setting, and participants: A total of 143 consecutive men with intermediate-or high-risk clinically localized adenocarcinoma of the prostate underwent robotic extended PLA and radical prostatectomy between September 2010 and November 2011 by a single surgeon. Surgical procedure: Lymph node packets were sent separately from bilateral common, external, and internal iliacs, obturators, node of Cloquet, and anterior prostatic fat. Measurements: Descriptive statistics were used to summarize lymph node yields and positive nodes. Clinical variables were examined in logistic regression models to predict lymph node positivity. Results and limitations: Median lymph node yield was 20 (range: 9-65, interquartile range: 15-25). Eighteen patients (13%) were found to have metastatic prostate cancer in the lymph nodes. The mean number of positive nodes foundwas 2.9 (range: 1-11). In 14 of 18 node-positive patients (78%), the extent of nodal invasion was outside the boundaries of a limited PLA. For four patients with positive nodes (22%), prostate biopsy predicted unilateral disease but PLA revealed contralateral positive lymph nodes. A total of 82% of patients experienced no complications, and most Clavien grade 1-2 complications consisted of anastomotic leakage, urinary retention, ileus, and lymphocele. Only 4% of patients experienced a grade 3 complication. Under multivariate regression analysis, prostate-specific antigen (PSA), clinical stage, and maximum biopsy core tumor volume were identified as significant predictors of finding positive pelvic lymph nodes (area under the curve: 91%). The main limitations include short follow-up and lack of randomization. Conclusions: Robotic extended bilateral PLA for prostate cancer up to the common iliac bifurcation increases nodal yield and positive nodal rate and can be performed safely. PSA, clinical stage, and maximum biopsy core volume are predictors for lymph node invasion. Long-term follow-up is needed to evaluate for therapeutic benefit. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1004 / 1010
页数:7
相关论文
共 50 条
  • [31] TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    McCammon, Robert
    Rusthoven, Kyle E.
    Kavanagh, Brian
    Newell, Sherri
    Newman, Francis
    Raben, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 413 - 420
  • [32] Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy
    Osmonov, D. K.
    Boller, A.
    Aksenov, A.
    Naumann, M.
    Juenemann, K. P.
    UROLOGE, 2013, 52 (02): : 240 - 245
  • [33] MAGNETOMETER GUIDED SENTINEL LYMPHADENECTOMY AFTER INTRAPROSTATIC INJECTION OF SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES IN INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER PATIENTS
    Winter, Alexander
    Engels, Svenja
    Goos, Philipp
    Sueykers, Marie-Christin
    Gudenkauf, Stefan
    Henke, Rolf-Peter
    Gerullis, Holger
    Wawroschek, Friedhelm
    JOURNAL OF UROLOGY, 2016, 195 (04): : E987 - E987
  • [34] Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer
    Bryant, Alex K.
    McKay, Rana R.
    Kader, A. Karim
    Parsons, J. Kellogg
    Einck, John P.
    Kane, Christopher J.
    Mundt, Arno J.
    Murphy, James D.
    Rose, Brent S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1068 - 1076
  • [35] Racial Disparities in the Management of African American Men With Intermediate- to High-Risk Prostate Cancer
    Mahal, B. A.
    Aizer, A. A.
    Ziehr, D. R.
    Hyatt, A. S.
    Sammon, J. D.
    Schmid, M.
    Choueiri, T. K.
    Hoffman, K. E.
    Hu, J. C.
    Sweeney, C. J.
    Beard, C. J.
    D'Amico, A. V.
    Martin, N. E.
    Kim, S. P.
    Trinh, Q.
    Nguyen, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S446 - S446
  • [36] The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.
    Arimura, Takeshi
    Kondo, Naoaki
    Matsukawa, Kyoko
    Wada, Kiyotaka
    Kitano, Ikumi
    Chuman, Ikuko
    Nagata, Ichiro
    Ogino, Takashi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [37] Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
    Lee, Hye Won
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (11) : 1631 - 1637
  • [38] THE EXTENT OF PELVIC LYMPH-NODE DISSECTION CORRELATES WITH THE BIOCHEMICAL RECURRENCE RATE IN PATIENTS WITH INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    Schiavina, Riccardo
    Baccos, Alessandro
    Borghesi, Marco
    Vagnoni, Valerio
    Zukerman, Ziv
    Romagnoli, Daniele
    Bertaccini, Alessandro
    Barbieri, Barbara
    Diazzi, Davide
    Bizzarri, Cosimo
    Manferrari, Fabio
    Martorana, Giuseppe
    ANTICANCER RESEARCH, 2011, 31 (05) : 1950 - 1951
  • [39] Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials - Reply
    Pommier, Pascal
    Chabaud, Sylvie
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2056 - 2057
  • [40] Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer, and confusion about the results of the randomized trials - In reply
    Nguyen, Paul L.
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3817 - 3818